WEBSITECHANGES

Website Changes

---

07/21/2021

KIYATEC Marks Glioblastoma Awareness Day by Initiating Use of 3D Predict™ Glioma Test Outside of Clinical Study

---

07/17/2021

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

---

07/10/2021

Nivolumab Plus Standard- or Reduced-Dosed Bevacizumab for Recurrent Glioblastoma

---

07/09/2021

Musella Foundation awards two brain tumor research grants!

---

07/06/2021

Prolonged survival after laser interstitial thermal therapy in glioblastoma

---

07/06/2021

Kansas advocate for brain cancer patients dies at 22 after giving voice to sick kids

---

07/03/2021

Virtualtrials.org website update

---

07/03/2021

Updated most of the survivor stories!

---

06/29/2021

Safety and Efficacy of Vorasidenib in Recurrent or Progressive Glioma

---

06/25/2021

Adjuvant—Not Concurrent—Temozolomide Upped Overall Survival in 1p/19q Non–Co-Deleted Anaplastic Glioma: Commentary on the CATNON Trial

---

06/24/2021

First Glioblastoma Patient Treated in Focused Ultrasound Clinical Trial at University of Virginia

---

06/24/2021

Musella Foundation Copay Assistance Program is now open!

---

06/20/2021

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

---

06/19/2021

Virtual Trials: Causally-validated treatment effects efficiently learned from an observational brain cancer registry

---

06/17/2021

Costly brain cancer drug no longer covered by Medicare

---

06/17/2021

Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay

---

06/14/2021

Save the Date! Promo Discount Code for National Walk To End Brain Tumors: Clark, NJ 7/24/21

---

06/14/2021

Veliparib + RT + TMZ in Patients With Unmethylated MGMT Glioblastoma

---

06/11/2021

Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma

---

06/10/2021

Promising New Legislation Could Transform the FDA`s Drug Approval Process, Leading to Better Treatments and Lower Prices

---

06/09/2021

Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit

---

06/08/2021

Y-mAbs Announces Update on Omburtamab for DIPG

---

06/06/2021

Musella Foundation awards two more brain tumor research grants!

---

06/04/2021

Market Research Opportunity for Patients and Caregivers

---

06/04/2021

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

---